Results 41 to 50 of about 41,675 (347)

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results [PDF]

, 2017
OBJECTIVES The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years ...
Boyle, Andrew J., Bruckner, Brian A., Chuang, Joyce, Estep, Jerry D., Farrar, David J., Haas, Donald C., Horstmanshof, Douglas A., Kasirajan, Vigneshwar, Lee, Sangjin, Long, James W., Milano, Carmelo A., Rogers, Joseph G., Selzman, Craig H., Shah, Keyur B., Starling, Randall C., Stehlik, Josef   +15 more
core   +2 more sources

Synergistic Model of Cardiac Function with a Heart Assist Device [PDF]

, 2019
The breakdown of cardiac self-organization leads to heart diseases and failure, the number one cause of death worldwide. The left ventricular pressure–volume relation plays a key role in the diagnosis and treatment of heart diseases.
Bestel, Haken, Knudsen, Simaan, Tuzun
core   +2 more sources

Simulation of dilated heart failure with continuous flow circulatory support [PDF]

, 2014
Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation.
A Ferreira, AG Rose, AM Katz, Antonio Ferreira, B Zaret, Bradley Keller, D Burkhoff, D Chung, D Morley, DA Kass, DJ Farrar, F Moscato, G Kovacs, H Schima, H Suga, I Nordenfelt, J Gorcsan III, J Ross, James Antaki, JC Matthews, John Gorcsan, JR Fitzpatrick III, JR Fitzpatrick III, KW Gwak, KW Gwak, LA Soloff, LW Stevenson, M Kinoshita, M Palardy, M Ursino, M Vollkron, MA Simon, MS Slaughter, Natasha Loghmanpour, NC Dang, O Lisy, PK Nair, RE Ehrsam, RL Kormos, RL Kormos, S Maybaum, S Nakatani, S Vandenberghe, SG Shroff, SJ Sarnoff, Stijn Vandenberghe, U Thadani, Vincenzo Lionetti, W Little, Y Shi, Yajuan Wang   +50 more
core   +4 more sources

3D printing is a transformative technology in congenital heart disease [PDF]

, 2018
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child.
Anwar, Anwar, Barach, Bernhard, Bhatla, Biglino, Biglino, Binder, Boneva, Borrello, Botto, Brown, Bucher, Byrne, Chaowu, Conti, Costello, Dearani, Deferm, Duan, Duan, Erikssen, Fan, Farooqi, Farooqi, Farooqi, Fleming, Fukunishi, Garekar, Gaynor, Gentles, Giamberti, Giannopoulos, Giroud, Gosnell, Grant, Green, Hadeed, Hermsen, Hoffman, Holst, Holst, Hu, Jacobs, Jana, Javan, Jonas, Kappetein, Kapur, Khairy, Kiraly, Kirklin, Kolli, Kotsis, Kung, Lee, Lee, Little, Lloyd-Jones, Mahle, Mahmood, Mannoor, Maragiannis, Markert, Markstedt, Mashari, Meier, Michael, Mitsouras, Moons, Moore, Morrison, Muraru, Ngan, Noecker, Olivieri, Olivieri, O’Brien, O’Neill, Pentecost, Poterucha, Randazzo, Rehder, Riesenkampff, Ripley, Rodriguez-Paz, Ryan, Saeed, Samuel, Santos dos, Schievano, Schmauss, Shah, Smith, Sodian, Sodian, Sutcliffe, Tabriz, Tack, Taylor, Valverde, VanKoevering, Vukicevic, Vukicevic, Vukicevic, Wang, Wang, Warnes, Warnes, Warnes, Whitlock, Wilasrusmee, Williams, Witschey, Yoo, Yoo, Zopf, Zweifel   +117 more
core   +3 more sources

Heart Rate Variability: A possible machine learning biomarker for mechanical circulatory device complications and heart recovery [PDF]

, 2020
Cardiovascular disease continues to be the number one cause of death in the United States, with heart failure patients expected to increase to \u3e8 million by 2030.
Aras, Shravan, Khalpey, Zain, Lin, Theodore   +2 more
core   +1 more source

Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy [PDF]

, 2015
Aim Dilated cardiomyopathy (DCM) has a variety of causes, and no useful approach to predict left ventricular (LV) remodelling and long-term outcome has yet been established.
Anzai, T, Ikeda, Y, Ishibashi-Ueda, H, Matsuyama, T-A, Nagai, T, Nakatani, T, Nakayama, T, Ogawa, H, Ohta-Ogo, K, Sugano, Y, Takeishi, Y, Yasuda, S, Yokokawa, T   +12 more
core   +1 more source

Right ventricular failure: Current strategies and future development

Frontiers in Cardiovascular Medicine, 2023
Right heart failure can be defined as a clinical syndrome consisting of signs and symptoms of heart failure resulting from right ventricular dysfunction. Function is normally altered due to three mechanisms: (1) pressure overload (2) volume overload, or (
María Monteagudo-Vela, María Monteagudo-Vela, Alexander Tindale, Alexander Tindale, Emilio Monguió-Santín, Guillermo Reyes-Copa, Vasileios Panoulas, Vasileios Panoulas   +7 more
doaj   +1 more source

Prediction, prevention, and management of right ventricular failure after left ventricular assist device implantation: A comprehensive review

Frontiers in Cardiovascular Medicine, 2022
Left ventricular assist devices (LVADs) are increasingly common across the heart failure population. Right ventricular failure (RVF) is a feared complication that can occur in the early post-operative phase or during the outpatient follow-up.
Eduard Rodenas-Alesina, Eduard Rodenas-Alesina, Eduard Rodenas-Alesina, Darshan H. Brahmbhatt, Darshan H. Brahmbhatt, Darshan H. Brahmbhatt, Vivek Rao, Vivek Rao, Marcus Salvatori, Filio Billia, Filio Billia   +10 more
doaj   +1 more source

Acute Hemodynamic Effects of Cardiac Resynchronization Therapy Versus Alternative Pacing Strategies in Patients With Left Ventricular Assist Devices

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background The hemodynamic effects of cardiac resynchronization therapy in patients with left ventricular assist devices (LVADs) are uncharacterized. We aimed to quantify the hemodynamic effects of different ventricular pacing configurations in patients ...
Brett Tomashitis, Catalin F. Baicu, Ross A. Butschek, Gregory R. Jackson, Jeffrey Winterfield, Ryan J. Tedford, Michael R. Zile, Michael R. Gold, Brian A. Houston   +8 more
doaj   +1 more source

Surgical embolectomy for acute massive pulmonary embolism: state of the art [PDF]

, 2018
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock.
De Bellis, Antonio, D’Abramo, Mizar, Frati, Giacomo, Greco, Ernesto, Iaccarino, Alessandra, Iovine, Elio, Saade, Wael, Schirone, Leonardo, Sciarretta, Sebastiano   +8 more
core   +1 more source